» Articles » PMID: 22162761

C-peptide Increases Na,K-ATPase Expression Via PKC- and MAP Kinase-dependent Activation of Transcription Factor ZEB in Human Renal Tubular Cells

Overview
Journal PLoS One
Date 2011 Dec 14
PMID 22162761
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Replacement of proinsulin C-peptide in type 1 diabetes ameliorates nerve and kidney dysfunction, conditions which are associated with a decrease in Na,K-ATPase activity. We determined the molecular mechanism by which long term exposure to C-peptide stimulates Na,K-ATPase expression and activity in primary human renal tubular cells (HRTC) in control and hyperglycemic conditions.

Methodology/principal Findings: HRTC were cultured from the outer cortex obtained from patients undergoing elective nephrectomy. Ouabain-sensitive rubidium ((86)Rb(+)) uptake and Na,K-ATPase activity were determined. Abundance of Na,K-ATPase was determined by Western blotting in intact cells or isolated basolateral membranes (BLM). DNA binding activity was determined by electrical mobility shift assay (EMSA). Culturing of HRTCs for 5 days with 1 nM, but not 10 nM of human C-peptide leads to increase in Na,K-ATPase α(1)-subunit protein expression, accompanied with increase in (86)Rb(+) uptake, both in normal- and hyperglycemic conditions. Na,K-ATPase α(1)-subunit expression and Na,K-ATPase activity were reduced in BLM isolated from cells cultured in presence of high glucose. Exposure to1 nM, but not 10 nM of C-peptide increased PKCε phosphorylation as well as phosphorylation and abundance of nuclear ERK1/2 regardless of glucose concentration. Exposure to 1 nM of C-peptide increased DNA binding activity of transcription factor ZEB (AREB6), concomitant with Na,K-ATPase α(1)-subunit mRNA expression. Effects of 1 nM C-peptide on Na,K-ATPase α(1)-subunit expression and/or ZEB DNA binding activity in HRTC were abolished by incubation with PKC or MEK1/2 inhibitors and ZEB siRNA silencing.

Conclusions/significance: Despite activation of ERK1/2 and PKC by hyperglycemia, a distinct pool of PKCs and ERK1/2 is involved in regulation of Na,K-ATPase expression and activity by C-peptide. Most likely C-peptide stimulates sodium pump expression via activation of ZEB, a transcription factor that has not been previously implicated in C-peptide-mediated signaling. Importantly, only physiological concentrations of C-peptide elicit this effect.

Citing Articles

Effects of C-Peptide on Dexamethasone-Induced In Vitro and In Vivo Models as a Potential Therapeutic Agent for Muscle Atrophy.

Kim J, Yang Y, Choi E, Lee S, Choi J Int J Mol Sci. 2023; 24(20).

PMID: 37895113 PMC: 10607908. DOI: 10.3390/ijms242015433.


Association of C-peptide level with bone mineral density in type 2 diabetes mellitus.

Yang H, Bai J, Li L, Yang Y, Zhang Y, Lv H Osteoporos Int. 2023; 34(8):1465-1476.

PMID: 37204453 DOI: 10.1007/s00198-023-06785-9.


The association between C-peptide and atrial cardiomyopathy in nondiabetic adults: results from NHANES III.

Zhou J, Yuan Y, Li X Heart Vessels. 2023; 38(8):1049-1055.

PMID: 36928669 DOI: 10.1007/s00380-023-02259-4.


Molecular Mechanism of Stimulation of Na-K-ATPase by Leukotriene D4 in Intestinal Epithelial Cells.

Nepal N, Arthur S, Butts M, Singh S, Palaniappan B, Sundaram U Int J Mol Sci. 2021; 22(14).

PMID: 34299188 PMC: 8303499. DOI: 10.3390/ijms22147569.


Biological Activity of c-Peptide in Microvascular Complications of Type 1 Diabetes-Time for Translational Studies or Back to the Basics?.

Ryk A, Losiewicz A, Michalak A, Fendler W Int J Mol Sci. 2021; 21(24).

PMID: 33419247 PMC: 7766542. DOI: 10.3390/ijms21249723.


References
1.
Thompson C, McDonough A . Skeletal muscle Na,K-ATPase alpha and beta subunit protein levels respond to hypokalemic challenge with isoform and muscle type specificity. J Biol Chem. 1996; 271(51):32653-8. DOI: 10.1074/jbc.271.51.32653. View

2.
Ekberg K, Brismar T, Johansson B, Lindstrom P, Juntti-Berggren L, Norrby A . C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy. Diabetes Care. 2006; 30(1):71-6. DOI: 10.2337/dc06-1274. View

3.
Al-Khalili L, Chibalin A, Yu M, Sjodin B, Nylen C, Zierath J . MEF2 activation in differentiated primary human skeletal muscle cultures requires coordinated involvement of parallel pathways. Am J Physiol Cell Physiol. 2004; 286(6):C1410-6. DOI: 10.1152/ajpcell.00444.2003. View

4.
Zhong Z, Kotova O, Davidescu A, Ehren I, Ekberg K, Jornvall H . C-peptide stimulates Na+, K+-ATPase via activation of ERK1/2 MAP kinases in human renal tubular cells. Cell Mol Life Sci. 2004; 61(21):2782-90. DOI: 10.1007/s00018-004-4258-x. View

5.
Craven P, Derubertis F . Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose. J Clin Invest. 1989; 83(5):1667-75. PMC: 303875. DOI: 10.1172/JCI114066. View